ArticleMethods in molecular biology (Clifton, N.J.)2026
Machine Learning Approaches for Interpretable Antibody Property Prediction Using Structural Data.
Article in Methods in molecular biology (Clifton, N.J.), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Understanding the relationship between antibody sequence, structure, and function is essential for the design of antibody-based therapeutics and research tools. Recently, machine learning (ML) models mostly based on the application of large language models to sequence information have been developed to predict antibody properties. Yet there are open directions to incorporate structural information, not only to enhance prediction but also to offer insights into the underlying molecular mechanisms. This chapter provides an overview of these approaches and describes two ML frameworks that integrate structural data (via graph representations) with neural networks to predict properties of antibodies: ANTIPASTI predicts binding affinity (a global property) whereas INFUSSE predicts residue flexibility (a local property). We survey the principles underpinning these models; the ways in which they encode structural knowledge; and the strategies that can be used to extract biologically relevant statistical signals that can help discover and disentangle molecular determinants of the properties of interest.
Indexed as
Identifiers
42680992What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.